Migraine headache is a condition that usually occurs unilaterally, with moderate to severe pain, often accompanied by vomiting, and is sensitive to light, sound, movement, and smell. To call “chronic migraine”, there must be a severe headache during at least half (15 days) of a month, and at least half of these headaches must be migraine-type. Chronic migraine greatly affects social life, physical and occupational performance. It ranks 19th among diseases that negatively affect living standards.
In the light of scientific data, Botulinum Toxin Type A has been used in the preventive treatment of Chronic Migraines since 2011.
Botulinum Toxin Type A treatment has been proven to reduce the frequency of migraine headaches providing significant benefits for patients. It can be applied to all patients with chronic migraines, except for children, women during pregnancy, and lactation. After multiple injections into some head, neck, and shoulder muscles in order to prevent migraine attacks, approximately 70% of patients see a reduction of more than 50% in the number of migraine days compared to pre-treatment. In addition, significant improvements are observed in the quality of life and the amount of disability related to headaches in these patients.
Our studies and experiences show that there is a significant improvement in the functions, psychological state, and general quality of life of patients as a result of Botulinum Toxin Type A treatment.
The main problem in migraine is in the nucleus of the trigeminal nerve, which receives the sensation of the face and neck. Botulinum Toxin Type A is applied to the sensory region of the trigeminal nerve and blocks the sensory nerves.
It is administered as 31 injections to a total of 7 areas at first. If necessary, 8 additional injections can be made.
It is administered as 7 injections to the forehead, which we call the frontal, 4 to the temples, which we call temporal, 3 to the back of the head, which we call the occipital, 3 injections to the neck region of the nape, and 3 injections to the trapezoidal muscle between the neck and shoulder.
It takes 5-10 minutes after the drug is prepared. You can then return to your work. It is enough not to rub that area for 24 hours. There may be swelling at the injection sites, but it will recede within 10 minutes with ice application.
In the treatment of chronic migraine, injections are recommended every 3 months for the first year, but the intervals can be determined in consultation with your doctor.